Evaluation of right ventricular fibrosis in adult congenital heart disease using gadolinium-enhanced magnetic resonance imaging: initial experience in patients with right ventricular loading conditions
- PMID: 18377526
- DOI: 10.1111/j.1747-0803.2006.00035.x
Evaluation of right ventricular fibrosis in adult congenital heart disease using gadolinium-enhanced magnetic resonance imaging: initial experience in patients with right ventricular loading conditions
Abstract
Objective: Gadolinium-enhanced cardiac magnetic resonance imaging has been used to show myocardial fibrosis, a finding that appears as late gadolinium enhancement. Its role in the evaluation of right ventricular fibrosis in congenital heart disease is unclear. The purpose of this study was to demonstrate late gadolinium enhancement of the right ventricle in adult and adolescent congenital heart disease and to investigate the relationship between this enhancement and clinical and pathophysiological data.
Design: In total, 24 patients, 16 patients with congenital heart disease and right ventricular loading conditions and 8 controls, underwent gadolinium-enhanced viability imaging. Diagnoses varied and included repaired, palliated, and unrepaired lesions. The presence and extent of right ventricular late gadolinium enhancement was compared with patient clinical and hemodynamic data. Exact Wilcoxon tests, Fisher's exact tests, and Spearman's rank correlation were used to compare variables.
Results: Nine of 16 patients (56%) were found to have right ventricular late gadolinium enhancement, ranging from 5% to 80% of right ventricular myocardium affected (mean 36.1%, SD 29.7). The combination of right ventricular systolic pressure >or=98 mm Hg and systemic oxygen saturation <or=93% strongly suggested the presence of right ventricular late gadolinium enhancement (positive predictive value 100%), but no single variable or combination of variables could reliably predict its absence (negative predictive values <or=75%). Extent of right ventricular late gadolinium enhancement did not correlate with degree of either hypoxia or right ventricular hypertension.
Conclusions: Gadolinium-enhanced cardiac magnetic resonance demonstrates right ventricular late gadolinium enhancement in some patients with congenital heart disease and right ventricular loading conditions. Clinical variables were associated with the presence of fibrosis but did not reliably predict severity. Myocardial preservation is likely a multifactorial process that may affect the right and left ventricles differently.
Similar articles
-
Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.Circ Heart Fail. 2010 Jan;3(1):51-8. doi: 10.1161/CIRCHEARTFAILURE.109.854026. Epub 2009 Oct 22. Circ Heart Fail. 2010. PMID: 19850699
-
Relation between right ventricular structural alterations and markers of adverse clinical outcome in adults with systemic right ventricle and either congenital complete (after Senning operation) or congenitally corrected transposition of the great arteries.Am J Cardiol. 2006 Nov 1;98(9):1277-82. doi: 10.1016/j.amjcard.2006.05.062. Epub 2006 Sep 14. Am J Cardiol. 2006. PMID: 17056346
-
Use of quantitative analysis of remote myocardial fibrosis with delayed-enhancement magnetic resonance imaging to predict outcomes after surgical ventricular restoration for ischemic cardiomyopathy.J Thorac Cardiovasc Surg. 2008 Dec;136(6):1514-21. doi: 10.1016/j.jtcvs.2008.03.037. Epub 2008 May 19. J Thorac Cardiovasc Surg. 2008. PMID: 19114200
-
Clinical applications of cardiac magnetic resonance imaging.Minerva Cardioangiol. 2009 Jun;57(3):299-313. Minerva Cardioangiol. 2009. PMID: 19513011 Review.
-
Non-invasive imaging in adult congenital heart disease using cardiovascular magnetic resonance.J Cardiovasc Med (Hagerstown). 2007 Jan;8(1):23-9. doi: 10.2459/01.JCM.0000247431.74699.9c. J Cardiovasc Med (Hagerstown). 2007. PMID: 17255812 Review.
Cited by
-
Late contrast enhancement by CMR: more than scar?Int J Cardiovasc Imaging. 2008 Aug;24(6):609-11. doi: 10.1007/s10554-008-9312-6. Epub 2008 Apr 23. Int J Cardiovasc Imaging. 2008. PMID: 18431687 Free PMC article. No abstract available.
-
Myocardial fibrosis in Eisenmenger syndrome: a descriptive cohort study exploring associations of late gadolinium enhancement with clinical status and survival.J Cardiovasc Magn Reson. 2014 May 14;16(1):32. doi: 10.1186/1532-429X-16-32. J Cardiovasc Magn Reson. 2014. PMID: 24886403 Free PMC article.
-
Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease.Circ Cardiovasc Imaging. 2010 Nov;3(6):727-34. doi: 10.1161/CIRCIMAGING.108.842096. Epub 2010 Sep 20. Circ Cardiovasc Imaging. 2010. PMID: 20855860 Free PMC article.
-
Duchenne muscular dystrophy; a cardiomyopathy that can be prevented?Int J Cardiovasc Imaging. 2009 Jan;25(1):65-7. doi: 10.1007/s10554-008-9370-9. Epub 2008 Oct 1. Int J Cardiovasc Imaging. 2009. PMID: 18830686 No abstract available.
-
Cardiac imaging in adults with congenital heart disease: unknowns and issues related to diagnosis.Curr Treat Options Cardiovasc Med. 2013 Oct;15(5):663-74. doi: 10.1007/s11936-013-0270-5. Curr Treat Options Cardiovasc Med. 2013. PMID: 24101413
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical